|
Volumn 35, Issue 9, 2007, Pages 521-523
|
Liver disease and renal dysfunction
|
Author keywords
hepatorenal syndrome; kidney diseases; liver cirrhosis; liver diseases
|
Indexed keywords
ACETYLCYSTEINE;
ALBUMIN;
AMINOGLYCOSIDE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIVIRUS AGENT;
CEFOTAXIME;
CIPROFLOXACIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FLUCONAZOLE;
FUROSEMIDE;
MIDODRINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
NORADRENALIN;
PARACETAMOL;
PENTOXIFYLLINE;
PIPERACILLIN PLUS TAZOBACTAM;
PREDNISOLONE;
SODIUM;
SPIRONOLACTONE;
STEROID;
TERLIPRESSIN;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ALCOHOL LIVER DISEASE;
ASCITES;
CHRONIC LIVER DISEASE;
DRUG OVERDOSE;
EARLY DIAGNOSIS;
EARLY INTERVENTION;
FLUID BALANCE;
HEMODYNAMICS;
HEPATORENAL SYNDROME;
HIGH RISK POPULATION;
HUMAN;
INFECTION;
INFECTION RISK;
KIDNEY BLOOD VESSEL;
KIDNEY DYSFUNCTION;
LIVER CIRRHOSIS;
LIVER TRANSPLANTATION;
PARACENTESIS;
PATHOGENESIS;
PORTOSYSTEMIC ANASTOMOSIS;
PRIORITY JOURNAL;
RENAL REPLACEMENT THERAPY;
REVIEW;
SODIUM BLOOD LEVEL;
SURVIVAL;
SYSTEMIC VASCULAR RESISTANCE;
VASOCONSTRICTION;
VASODILATATION;
|
EID: 34548156297
PISSN: 13573039
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mpmed.2007.06.004 Document Type: Review |
Times cited : (1)
|
References (8)
|